FDA Approves Trastuzumab Biosimilar to Treat Forms of HER2-Overexpressing Cancer
Trastuzumab is indicated for adjuvant breast cancer, metastatic breast cancer, and gastric cancer.
Stay updated with breaking news from Several Forms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trastuzumab is indicated for adjuvant breast cancer, metastatic breast cancer, and gastric cancer.
Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. ...
Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. ...
Share this article Share this article ResearchAndMarkets.com's offering. COVID-19 Accelerates Acceptance of Vegetarianism & Also the Emphasis on the Environment. Protein Alternatives to Gain $4.7 Billion on Both Counts The global market for Protein Alternatives is projected to reach US$4.7 billion by the year 2027, trailing a post COVID-19 CAGR of 8% over the analysis period 2020 through 2027. Non-animal based sources of protein are environmentally sustainable as compared to crop and animal based sources. By the year 2050, approximately 75% more food will be required to feed the population ...